In early June, three new people joined the BII team: Hervør Lykke Olsen in scientific development, Bo Heinemann in laboratory facilities, and Casper Linnemann in communication. With these three new members, the team has grown to nine full time members plus two part time employees over the past months.
“It is in our strategy to build a lean organization and we are at a point in time where we need profiles that have a strategic approach but also a drive to pull up their sleeves and be operational. In that way, BII is no different than a start-up”, says director Thomas Nagy.
In scientific development, Hervør will be in close contact with the projects accepted to BII. She comes from Novo Nordisk and has been project manager on a new synthetic GLP-1 analogue. She has previously worked at Sophion Bioscience, handling international collaborations between industry and universities.
Bo will be in charge of developing BII’s state of the art lab facilities. For the past three years, he has directed all kinds of pre-clinical method development work in Gruba, including setting up relevant technologies. Before that, he actually set up labs for Epitherapeutics at the COBIS building where the BII has also moved to.
Casper will be on top of everything related to communication: networks and partnerships, social media, and events to name a few. During the past four years, Casper has worked at the international startup accelerator Accelerace with a special responsibility with life science communications.